Lindsey Kuehm, PhD

Lindsey Kuehm, PhD has a diverse work experience beginning in 2012 as a QC Microbiologist at Neos Therapeutics. In 2014, they moved to Bristol-Myers Squibb where they continued their role as a QC Microbiologist until 2015. From 2015 to 2020, Lindsey worked as a Graduate Student at Saint Louis University, conducting research on the influence of diet and obesity on responses to checkpoint blockade immunotherapy in cancer. In 2020, they joined TCRCure Biopharma Corp. as a Scientist, a position they held until 2022. Lindsey then transitioned to Cell Microsystems as a Field Application Scientist from 2022 to 2023. Currently, Lindsey is a Research Scientist I-Project Lead at Altis Biosystems since 2023.

Lindsey Kuehm, PhD, began their education in 2004 at the University of North Texas where they pursued a Bachelor's degree in Biology, with a focus on General Biology. Lindsey successfully completed their undergraduate studies in 2008. Following this, they attended UNT Health Science Center from 2010 to 2012 and obtained a Master's degree with a specialization in Microbiology and Immunology. Lindsey continued their educational journey at Saint Louis University from 2015 to 2020, where they earned a Doctor of Philosophy (PhD) degree in Immunology.